Flumazenil → Flumazenil Impurity 8

HRID 67291

Reaktionsgleichung

Reaktionsgleichung von HRID 67291
[F:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]3[CH:12]=[N:13][C:14]([C:15]([O:17][CH2:18]C)=[O:16])=[C:10]3[CH2:9][N:8]([CH3:20])[C:7](=[O:21])[C:6]=2[CH:22]=1.[C-]#N.[K+]>CO>[F:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]3[CH:12]=[N:13][C:14]([C:15]([O:17][CH3:18])=[O:16])=[C:10]3[CH2:9][N:8]([CH3:20])[C:7](=[O:21])[C:6]=2[CH:22]=1

Komponenten

4

Versuchsvorschrift

A mixture of 3.5 g (11.5 mmol) of ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate, 0.15 g of potassium cyanide and 40 ml of methanol is stirred at the boiling point for 2.5 hours. The solvent is distilled off on a rotary evaporator and the residue is taken up in chloroform. After filtration from insoluble material, the filtrate is concentrated. After recrystallisation of the residue from ethyl acetate, there is obtained methyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate of melting point 195°-196.5° C.

Aufarbeitung

  1. distillationThe solvent is distilled off on a rotary evaporator
  2. filtrationAfter filtration from insoluble material
  3. concentrationthe filtrate is concentrated
  4. customAfter recrystallisation of the residue from ethyl acetate

Quellen und Nachweise

ORD-Eintrag
ord-f7907057e5664da08afc69dfee8916dc
Quelldatensatz
uspto-grants-1982_08
Patentnummer
US04346030

Verknüpfte Notizen

Wird geladen…